[2]
Ansari S, Understanding the Impact of Chronic Obstructive Pulmonary Disease and Intervening to Improve Self-Management in the Context of Multi-morbidity. International journal of integrated care. 2018 Jul 19 [PubMed PMID: 30093845]
[3]
Kheradmand F,You R,Hee Gu B,Corry DB, Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema. Transactions of the American Clinical and Climatological Association. 2017 [PubMed PMID: 28790504]
[4]
Nicolini A,Barbagelata E,Tagliabue E,Colombo D,Monacelli F,Braido F, Gender differences in chronic obstructive pulmonary diseases: a narrative review. Panminerva medica. 2018 Jun 1 [PubMed PMID: 29856178]
[5]
Sana A,Somda SMA,Meda N,Bouland C, Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ open respiratory research. 2018 [PubMed PMID: 29387422]
[6]
Nagaraj C,Tabeling C,Nagy BM,Jain PP,Marsh LM,Papp R,Pienn M,Witzenrath M,Ghanim B,Klepetko W,Weir EK,Heschl S,Kwapiszewska G,Olschewski A,Olschewski H, Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox. The European respiratory journal. 2017 Jul [PubMed PMID: 28729471]
[7]
Dunham-Snary KJ,Wu D,Sykes EA,Thakrar A,Parlow LRG,Mewburn JD,Parlow JL,Archer SL, Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine. Chest. 2017 Jan [PubMed PMID: 27645688]
[8]
Viniol C,Vogelmeier CF, Exacerbations of COPD. European respiratory review : an official journal of the European Respiratory Society. 2018 Mar 31 [PubMed PMID: 29540496]
[9]
Kobayashi S,Nishimura M,Yamamoto M,Akiyama Y,Miyamoto K,Kawakami Y, Respiratory load compensation during hypercapnic ventilatory response in pulmonary emphysema. Chest. 1994 May [PubMed PMID: 8181326]
[10]
Inkrott JC, Understanding Hypoxic Drive and the Release of Hypoxic Vasoconstriction. Air medical journal. 2016 Jul-Aug [PubMed PMID: 27393755]
[11]
O'Donnell DE,Banzett RB,Carrieri-Kohlman V,Casaburi R,Davenport PW,Gandevia SC,Gelb AF,Mahler DA,Webb KA, Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proceedings of the American Thoracic Society. 2007 May [PubMed PMID: 17494725]
[12]
Ucgun I,Oztuna F,Dagli CE,Yildirim H,Bal C, Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia. Respiration; international review of thoracic diseases. 2008 [PubMed PMID: 18463428]
[14]
Kreppein U,Litterst P,Westhoff M, [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management]. Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2016 Apr [PubMed PMID: 26902369]
[15]
Schiavo A,Renis M,Polverino M,Iannuzzi A,Polverino F, Acid-base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward. Multidisciplinary respiratory medicine. 2016 [PubMed PMID: 27226896]
[16]
Kayacan O,Beder S,Deda G,Karnak D, Neurophysiological changes in COPD patients with chronic respiratory insufficiency. Acta neurologica Belgica. 2001 Sep [PubMed PMID: 11817264]
[17]
Manca-Di-Villahermosa S,Tedesco M,Lonzi M,Della-Rovere FR,Innocenzi A,Colarieti G,Favarò A,Chamoun GM,Taccone-Gallucci M, Acid-base balance and oxygen tension during dialysis in uremic patients with chronic obstructive pulmonary disease. Artificial organs. 2008 Dec [PubMed PMID: 19133027]
[18]
Herren T,Achermann E,Hegi T,Reber A,Stäubli M, Carbon dioxide narcosis due to inappropriate oxygen delivery: a case report. Journal of medical case reports. 2017 Jul 28 [PubMed PMID: 28750686]
[19]
Rocker G, Harms of overoxygenation in patients with exacerbation of chronic obstructive pulmonary disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2017 Jun 5 [PubMed PMID: 28584039]
[20]
Cameron L,Pilcher J,Weatherall M,Beasley R,Perrin K, The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgraduate medical journal. 2012 Dec [PubMed PMID: 22977283]
[21]
Raherison C,Ouaalaya EH,Bernady A,Casteigt J,Nocent-Eijnani C,Falque L,Le Guillou F,Nguyen L,Ozier A,Molimard M, Comorbidities and COPD severity in a clinic-based cohort. BMC pulmonary medicine. 2018 Jul 16 [PubMed PMID: 30012144]
[22]
Culver BH, Assessment of severity and prognosis in COPD: moving beyond percent of predicted. The European respiratory journal. 2018 Aug [PubMed PMID: 30072543]
[23]
Sadatsafavi M,Ghanbarian S,Adibi A,Johnson K,FitzGerald JM,Flanagan W,Bryan S,Sin D, Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada. Medical decision making : an international journal of the Society for Medical Decision Making. 2019 Jan 24; [PubMed PMID: 30678520]